Merrill Lynch Keeps Their Hold Rating on Johnson & Johnson (JNJ)

By Carrie Williams

Merrill Lynch analyst Bob Hopkins maintained a Hold rating on Johnson & Johnson (JNJResearch Report) today and set a price target of $150. The company’s shares closed yesterday at $134.71.

According to, Hopkins is a 4-star analyst with an average return of 11.2% and a 71.4% success rate. Hopkins covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems Inc, Silk Road Medical Inc, and Intuitive Surgical.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Johnson & Johnson with a $150.50 average price target.

See today’s analyst top recommended stocks >>

Johnson & Johnson’s market cap is currently $357.7B and has a P/E ratio of 24.95. The company has a Price to Book ratio of 6.07.

Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of JNJ in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.